Peg-Filgrastim
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Peg-Filgrastim, covering 2017-06-28 to 2021-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer [Phase 4]